| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |